CAH
vs
S&P 500
Over the past 12 months, CAH has underperformed S&P 500, delivering a return of 18% compared to the S&P 500's 24% growth.
Stocks Performance
CAH vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
IT |
Amplifon SpA
MIL:AMP
|
||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
Performance Gap
CAH vs S&P 500
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
IT |
Amplifon SpA
MIL:AMP
|
||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
Performance By Year
CAH vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
IT |
Amplifon SpA
MIL:AMP
|
||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
Competitors Performance
Cardinal Health Inc vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
LU |
Tenaris SA
MIL:TEN
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Cardinal Health Inc
Glance View
Cardinal Health Inc., a formidable player in the healthcare sector, operates with the intricacy and precision of a well-orchestrated symphony. At its core, the company thrives on the distribution of pharmaceuticals and medical products, deftly weaving through the complexities of the healthcare supply chain. Cardinal Health serves as a lifeline connecting manufacturers on one end to healthcare providers and pharmacies on the other, ensuring that vital medications and supplies reach those in need efficiently. With a robust logistics network and sophisticated information systems, the company navigates a sprawling array of over 46,000 products, delivering them with diligence to hospitals, clinics, and retail pharmacies across the globe. In its pursuit of business ingenuity, Cardinal Health has expanded its horizons beyond distribution. The company ventures into the vibrant realm of medical and surgical products, offering an array of services that cater to clinical laboratories, ambulatory surgery centers, and more. This diversification not only amplifies its revenue streams but also aligns with its strategic goal of building a comprehensive healthcare ecosystem. Cardinal Health earns its income by capitalizing on a combination of service fees, margins from product sales, and a spectrum of value-added solutions. This intricate blend allows the company to maintain a competitive edge in an era where healthcare demands are ever-evolving and cost-efficiency is paramount. This finely tuned business model is what enables Cardinal Health to sustain its economic vitality and continue its transformative impact on healthcare delivery.